Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficiency of Hydroxychloroquine on the Endothelial Dysfunction in Antiphospholipid Syndrome (APLAQUINE)

NCT02595346 is registered in ClinicalTrials.gov with University Hospital, Rouen as lead sponsor.

NCT NCT02595346
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02595346 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficiency of Hydroxychloroquine on the Endothelial Dysfunction in Antiphospholipid Syndrome (APLAQUINE)
Lead sponsor
University Hospital, Rouen
Phase
Phase 2
Overall status
Terminated
Start date
May 17, 2016
Completion date
August 5, 2020
Enrollment
25 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

antiphospholipid syndrome (aps)